ライフサイエンスコーパス: nuclear medicine

1 s 2000 for all imaging modalities other than nuclear medicine.

2 ain subspecialties, including pediatrics and nuclear medicine.

3 argets and thus playing an important role in nuclear medicine.

4 n vitro methods is an important challenge in nuclear medicine.

5 icients for risk analysis of the patients in nuclear medicine.

6 larity to pertechnetate, both having uses in nuclear medicine.

7 ic phantoms in many clinical applications in nuclear medicine.

8 rently in the spotlight of radiopharmacy and nuclear medicine.

9 n and procedure standardization in pediatric nuclear medicine.

10 valuable for improved diagnostics in routine nuclear medicine.

11 iative backed by the European Association of Nuclear Medicine.

12 of the pivotal role of (99m)Tc in diagnostic nuclear medicine.

13 risk estimation in the context of pediatric nuclear medicine.

14 y in preclinical cancer research but also in nuclear medicine.

15 s for use in both diagnostic and therapeutic nuclear medicine.

16 ed a general overview of machine learning in nuclear medicine.

17 l procedures commonly performed in pediatric nuclear medicine.

18 s considered optimization projects regarding nuclear medicine.

19 y (SPECT), comprise the imaging component of nuclear medicine.

20 gnostic imaging and targeted radiotherapy in nuclear medicine.

21 for the practices of pediatric radiology and nuclear medicine.

22 illustrations of when they can be helpful in nuclear medicine.

23 one according to the European Association of Nuclear Medicine 2015 guidelines for (18)F-FDG PET/CT im

24 ere the those of the European Association of Nuclear Medicine (60%).

25 Initiated by the German Society of Nuclear Medicine, a retrospective multicenter data analy

26 rs and represents a shift toward activatable nuclear medicine agents.

27 Two nuclear medicine and 2 genitourinary radiologists indepe

28 c electronics and photonics, drug discovery, nuclear medicine and complex molecule synthesis, because

29 tellar nucleosynthesis, reactor performance, nuclear medicine and defence applications.

30 clide excretion or retention is important in nuclear medicine and following accidental/malicious radi

31 nical Trials Network (CTN) of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) operates

32 The Society of Nuclear Medicine and Molecular Imaging and the American

33 d in protocols compliant with the Society of Nuclear Medicine and Molecular Imaging and the European

34 scanner validation program of the Society of Nuclear Medicine and Molecular Imaging Clinical Trials N

35 hods: Data were acquired with the Society of Nuclear Medicine and Molecular Imaging Clinical Trials N

36 canned a phantom developed by the Society of Nuclear Medicine and Molecular Imaging Clinical Trials N

37 roendocrine Tumor Society and the Society of Nuclear Medicine and Molecular Imaging collaborated to d

38 e Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging convened the Amyl

39 er disorders of gastric motility; Society of Nuclear Medicine and Molecular Imaging guidelines are pr

40 g, performed according to current Society of Nuclear Medicine and Molecular Imaging guidelines, serve

41 the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging previously publis

42 y, American College of Radiology, Society of Nuclear Medicine and Molecular Imaging, American Urologi

43 ped by the RADAR committee of the Society of Nuclear Medicine and Molecular Imaging, based on 2007 re

44 tic Resonance in Medicine and the Society of Nuclear Medicine and Molecular Imaging.

45 iew of established and emerging conventional nuclear medicine and PET imaging biomarkers, as the diag

46 dicine departments (n = 13, 33%), jointly by nuclear medicine and radiology (n = 11, 28%), and radiol

47 his study were to evaluate trained readers' (nuclear medicine and radiology physicians) visual assess

48 n of knowledge and technological advances in nuclear medicine and radiology require physicians to hav

49 changes have unmasked weaknesses in current nuclear medicine and radiology training programs.

50 ultrasonography, magnetic resonance imaging, nuclear medicine, and genomic techniques, such as real-t

51 journals in the subject category "radiology, nuclear medicine, and medical imaging" at the Institute

52 ial utility to the fields of radiochemistry, nuclear medicine, and molecular imaging.

53 nuclear reactors created the opportunity for nuclear medicine, and one of the co-inventors of MRI was

54 pe, whether the hospital practices pediatric nuclear medicine, and the hospital's method for determin

55 aphy [CT], magnetic resonance imaging [MRI], nuclear medicine, and ultrasound).

56 ents who may have been discouraged without a nuclear medicine approach.

57 ar imaging heightens the promise of clinical nuclear medicine as a tool for individualization of pati

58 In this way, the full potential of nuclear medicine as an effective and efficient tool for

59 sought to describe the practice of pediatric nuclear medicine at general hospitals in the United Stat

60 spective to the available radiologic- and/or nuclear medicine-based imaging technologies.

61 ude mammography, MR imaging, ultrasound, and nuclear medicine-based methods such as (99m)Tc-sestamibi

62 omplement the routinely used radiologic- and nuclear medicine-based modalities.

63 ng with three-dimensional radiologic- and/or nuclear medicine-based preinterventional imaging may ove

64 ployment prospects for physicians trained in nuclear medicine but not also trained in diagnostic radi

65 -99m, the most commonly used radionuclide in nuclear medicine, can be attached to biologically import

66 nowadays the widely used echocardiographic, nuclear medicine, cardiac computed tomographic (CT), and

67 o data published regarding the proportion of nuclear medicine centers using SPECT or SPECT/CT rather

68 (NSCLC) patients, we investigated whether 18 nuclear medicine centers would score tracer uptake inten

69 At three tertiary nuclear medicine centres, we used whole body planar imag

70 sufficient pool of incoming highly qualified nuclear medicine clinicians.

71 on schema can be successfully implemented by nuclear medicine clinics seeking to improve their approa

72 Our aim was to investigate how far the nuclear medicine community has come on its way from accu

73 We argue that an optimistic outlook by the nuclear medicine community is crucial to the growth of t

74 t of a multidisciplinary team and involves a nuclear medicine consultation service, tumor board, and

75 n introduction to machine learning (ML) in a nuclear medicine context.

76 radiolabeled drugs, metabolic precursors and nuclear medicine contrast agents) by single cells withou

77 this background, the ACR and the Society of Nuclear Medicine convened the Task Force on Nuclear Medi

78 were heterogeneous (European Association of Nuclear Medicine criteria, 35%; Prospective Investigatio

79 the dose rate from NET patients exiting the nuclear medicine department after undergoing PET/CT with

80 Any nuclear medicine department equipped with a modern hybri

81 Thus, when exiting the nuclear medicine department, the NET patients injected w

82 Systems were primarily operated by nuclear medicine departments (n = 13, 33%), jointly by n

83 lability of (99m)Tc has become a concern for nuclear medicine departments across the globe.

84 The impact of the pandemic on nuclear medicine departments and their services has not

85 ion to the special needs of this population, nuclear medicine departments can successfully study pati

86 The between-center agreement (18 nuclear medicine departments connected with a dedicated

87 multiple-choice questions was distributed to nuclear medicine departments in Australia, Canada, and F

88 impact of the pandemic on in- and outpatient nuclear medicine departments, including the number of pr

89 ey was to evaluate the impact of COVID-19 on nuclear medicine departments.

90 PET images were independently reviewed by 2 nuclear medicine diagnosticians with at least 2 y of exp

91 ast decade, it has also become apparent that nuclear medicine (e.g., in the form of bimodal/hybrid tr

92 ion program from the European Association of Nuclear Medicine (EANM) (PSFEARL).

93 ular Imaging and the European Association of Nuclear Medicine (EANM) acquisition guidelines and were

94 were published: the European Association of Nuclear Medicine (EANM) criteria, the Prostate Cancer Mo

95 stered doses and the European Association of Nuclear Medicine (EANM) Dosage Card guidelines recommend

96 cer in the 1940s, remarkable achievements in nuclear medicine endoradiotherapy have been demonstrated

97 ions increased by an average of 7% per year, nuclear medicine examinations by 12% per year, and compu

98 le patient's dose accumulation from multiple nuclear medicine examinations was created.

99 ional radiologic examinations and 18 million nuclear medicine examinations were performed.

100 diologic, 0.5 billion dental, and 37 million nuclear medicine examinations) are performed annually.

101 stinct group of trainees who want to combine nuclear medicine expertise with therapy including patien

102 ional workshop attended by hematologists and nuclear medicine experts in Deauville, France, proposed

103 Two nuclear medicine experts manually delineated foci with i

104 were reviewed by an international panel of 6 nuclear medicine experts using the 5-point score.

105 showing only moderate reproducibility among nuclear medicine experts, indicate the need to standardi

106 can be used for SLN biopsy in settings where nuclear medicine facilities are not available, albeit wi

107 entifying structures and patterns present in nuclear medicine flood-field uniformity images.

108 is an artificial beta emitter widely used in nuclear medicine for diagnostic tests.

109 T with (18)F-FDG is the standard modality in nuclear medicine for imaging multiple myeloma (MM).

110 ostics has been used in clinical routines in nuclear medicine for more than 60 y-as (131)I for diagno

111 ics, is among the most promising concepts in nuclear medicine for optimizing and individualizing trea

112 adjunctive nonradioactive pharmaceuticals in nuclear medicine from 2007 to 2011.

113 Pediatric patients are referred to nuclear medicine from nearly all pediatric specialties i

114 r imaging data acquired in the department of nuclear medicine guides the surgical management of patie

115 Nuclear medicine has an important role in the care of ne

116 e molecular imaging and radioguided surgery, nuclear medicine has been instrumental in the realizatio

117 g and peptide receptor radionuclide therapy, nuclear medicine has earned a major role in gastroentero

118 tion Dose (MIRD) Committee of the Society of Nuclear Medicine has provided a broad framework for asse

119 Over the 75 y of its existence, the field of nuclear medicine has rejuvenated itself repeatedly by we

120 In particular, nuclear medicine has seen the development of several rad

121 or the use of radiolabeled nanoparticles in nuclear medicine, has attracted much attention in the la

122 In this Journal of Nuclear Medicine Hot Topics discussion, we review the hi

123 Three percent of nuclear medicine images showed alternative findings such

124 e pertechnetate was identified on 38% of the nuclear medicine images.

125 embolization treatment planning makes use of nuclear medicine imaging (NMI) of (99m)Tc-macroaggregate

126 ly less than what is normally observed using nuclear medicine imaging agents.

127 n the quickly evolving field of radiomics in nuclear medicine imaging and associated oncology applica

128 ese data are newly emerging and preliminary, nuclear medicine imaging approaches might advance our un

129 o the CSF intraventricular space followed by nuclear medicine imaging at 90 min, 4 h, 24 h, and 48 h

130 Nuclear medicine imaging declined in adults and children

131 HYPR-LR processing holds great potential in nuclear medicine imaging for all applications with low S

132 rts to reduce radiation exposure from CT and nuclear medicine imaging in accord with the as-low-as-re

133 PA)-octreotide scintigraphy is currently the nuclear medicine imaging modality of choice for identify

134 in the activity administered for diagnostic nuclear medicine imaging of children.

135 r SISCOM and (18)F-FDG PET results together, nuclear medicine imaging techniques showed coinciding vi

136 While traditionally nuclear medicine imaging techniques, in particular posit

137 of using A9 as HER2- specific probe for the nuclear medicine imaging was evaluated by conjugating A9

138 macroscopic and microscopic optical imaging, nuclear medicine imaging, MRI, and even photoacoustic im

139 offers advantages for pediatric sedation for nuclear medicine imaging.

140 dmission and confirmed by ultrasound, CT, or nuclear medicine imaging.

141 tic resonance imaging (MRI), ultrasound, and nuclear medicine imaging.

142 North American guidelines on the practice of nuclear medicine in children at 13 dedicated pediatric i

143 To determine the role of nuclear medicine in surgical guidance, in particular the

144 Nuclear medicine in the United States has grown because

145 To determine the role of nuclear medicine, in particular the positional guidance

146 dicated network, SFMN-net [French Society of Nuclear Medicine]) in the scoring of uptake intensity (5

147 Yet, there are concerns about the future of nuclear medicine, including progressively declining reim

148 If the nuclear medicine industry is able to continue to effecti

149 Nuclear medicine is composed of two complementary areas,

150 m)Tc for single-photon imaging in diagnostic nuclear medicine is crucial, and current availability is

151 n prospective clinical trials in theranostic nuclear medicine is essential.

152 Nuclear medicine is experiencing a renaissance, with U.S

153 astly, radiation dose reduction in pediatric nuclear medicine is explicated.

154 elation to targeting molecules in diagnostic nuclear medicine is presented.

155 A potential milestone in personalized nuclear medicine is theranostics of metastatic castratio

156 The value of pediatric nuclear medicine is well established.

157 urveys of radiopharmaceutical doses for U.S. nuclear medicine laboratories are of limited scope and s

158 o attract the best and brightest students to nuclear medicine, leaders and mentors in the field must

159 als and techniques, including polarographic, nuclear medicine, magnetic resonance, and optical approa

160 was sent electronically to 13,221 Society of Nuclear Medicine members and radiation oncologists throu

161 tor studies (this publication will not cover nuclear medicine methods) are not routinely used.

162 possible to visually assess IDDS systems by nuclear medicine methods.

163 Although the multidisciplinary nature of nuclear medicine (NM) and clinical molecular imaging is

164 The practice of nuclear medicine (NM) in the Latin American and Caribbea

165 estimate the risk of cataract in a cohort of nuclear medicine (NM) radiologic technologists on the ba

166 Eighty-two hospitals (67.8%) performed nuclear medicine on children.

167 ual board-certified, 10% residents in either nuclear medicine or radiology, and 5% medical physicists

168 uted tomography, magnetic resonance imaging, nuclear medicine) ordered by 164 primary care and 379 me

169 lizers, or radionuclides in recently treated nuclear medicine patients.

170 of interest, reviewed by consensus between a nuclear medicine physician and a radiation oncologist, w

171 operatively evaluated by a radiologist and a nuclear medicine physician and prospectively documented.

172 wo teams composed of one radiologist and one nuclear medicine physician each, read all 134 studies.

173 ologist, experienced in CT colonography, and nuclear medicine physician in consensus analyzed the dat

174 Two radiologists and a nuclear medicine physician in consensus evaluated the fo

175 2 radiology residents and 1 board-certified nuclear medicine physician independently and then in con

176 Clinical assessment was also performed by a nuclear medicine physician to determine amyloid status b

177 ans by comparing the annotations of a second nuclear medicine physician to the first reader in 20 of

178 c accuracy by an experienced radiologist and nuclear medicine physician were performed.

179 ed with manual readings in a subcohort (by 1 nuclear medicine physician).

180 Interpretation by the primary nuclear medicine physician, who had access to all clinic

181 )Ga-PSMA-11 PET/CT images were analyzed by a nuclear medicine physician.

182 ll PET/CT scans (n = 204) were reviewed by 1 nuclear medicine physician.

183 ration by a dedicated medical oncologist and nuclear medicine physician.

184 images (acquired between 2005 and 2011) by a nuclear medicine physician.

185 us and heterogeneous lesions as defined by 2 nuclear medicine physicians (P < 0.05).

186 Nuclear medicine physicians and radiologists will need m

187 onstructed images were blindly reviewed by 3 nuclear medicine physicians and scored (using a Likert s

188 mage analysis was performed by 3 independent nuclear medicine physicians applying the molecular imagi

189 analysis was performed by three independent nuclear medicine physicians applying the molecular imagi

190 n of TOF and non-TOF images performed by two nuclear medicine physicians confirmed the advantages of

191 at as these agents are clinically onboarded, nuclear medicine physicians have the expertise to deploy

192 The images were evaluated by 2 experienced nuclear medicine physicians in consensus, both qualitati

193 Images were reviewed by 2 nuclear medicine physicians in consensus, with the prese

194 aminations were reviewed by radiologists and nuclear medicine physicians in consensus.

195 This study provides guidance for nuclear medicine physicians in interpreting texture indi

196 Three nuclear medicine physicians independently evaluated all

197 Four nuclear medicine physicians independently reviewed the o

198 2011 and before 2009, with a shift away from nuclear medicine physicians providing instructions after

199 Two nuclear medicine physicians reviewed all scans, first id

200 Three experienced nuclear medicine physicians then scored each striatum as

201 hip prostheses were scored by 2 experienced nuclear medicine physicians to analyze clinical relevanc

202 CT scans were prospectively reevaluated by 3 nuclear medicine physicians using a structured scoring s

203 more commonly early career radiologists, and nuclear medicine physicians were later career radiologis

204 Images were assessed by 5 nuclear medicine physicians who had limited prior experi

205 ied in the dose-ranging study, 3 independent nuclear medicine physicians who were masked to all clini

206 erpretation was performed independently by 2 nuclear medicine physicians who were not aware of the cl

207 The studies were interpreted by 2 nuclear medicine physicians who were unaware of the labo

208 scintigraphy scans were examined by 2 expert nuclear medicine physicians with a scoring method that a

209 In addition, this article provides nuclear medicine physicians with the background knowledg

210 preablation radioiodine imaging and provides nuclear medicine physicians with the background knowledg

211 age interpretation (based on the median of 3 nuclear medicine physicians' ratings) and semiautomated

212 approach was performed in a subcohort (by 2 nuclear medicine physicians).

213 PET/CT studies were interpreted by 2 nuclear medicine physicians, and discrepancies were reso

214 Two nuclear medicine physicians, blinded to the patient data

215 PET/CT studies were interpreted by 3 nuclear medicine physicians, independently.

216 oncologists, pathologists, radiologists, and nuclear medicine physicians, representing major internat

217 tapir scans (majority interpretation of five nuclear medicine physicians, who classified each scan as

218 All scans were interpreted by 4 nuclear medicine physicians.

219 visually scored (3-level scale [Hvisu]) by 2 nuclear medicine physicians.

220 tly interpreted by teams of radiologists and nuclear medicine physicians.

221 artition modeling was planned by experienced nuclear medicine physicians.

222 ted images were qualitatively evaluated by 3 nuclear medicine physicians.

223 PET images were interpreted by two pediatric nuclear medicine physicians.

224 Three dual-accredited nuclear medicine physicians/radiologists identified the

225 n observer study was performed with 5 expert nuclear medicine physicists.

226 nd PET imaging biomarkers, as the diagnostic nuclear medicine portfolio is rapidly expanding.

227 r as well as becoming an important aspect of nuclear medicine practice in the future.

228 s have had a substantial impact on pediatric nuclear medicine practice in the United States.

229 view first will cover the general aspects of nuclear medicine practice with these patients, including

230 re cost-effectiveness data and evidence that nuclear medicine procedures affect patients' outcomes.

231 ncy and associated doses from radiologic and nuclear medicine procedures are rarely conducted.

232 red about the administered activities for 16 nuclear medicine procedures commonly performed on childr

233 Conclusion: Both diagnostic and therapeutic nuclear medicine procedures declined precipitously, with

234 procedures (eg, diagnostic fluoroscopy) and nuclear medicine procedures decreased from 17 million to

235 Patients undergoing nuclear medicine procedures for cancer therapy are admin

236 he radiation dose received by the fetus from nuclear medicine procedures is important because of the

237 m radiologic procedures and organ doses from nuclear medicine procedures, along with Biologic Effects

238 e highlight the possible impact of AI on the nuclear medicine profession, the associated challenges a

239 A nuclear medicine radiologist (blinded to correlative and

240 ng collaboration between radiation oncology, nuclear medicine/radiology, and medical physics teams is

241 egrated structure-function imaging, clinical nuclear medicine reaches beyond traditional specialty bo

242 Only 38% (330 of 867) of SRs on radiology or nuclear medicine-related imaging published from January

243 ure data can be extracted from institutional nuclear medicine report archives with high recall and pr

244 ing, manual validation was performed on 2359 nuclear medicine reports randomly selected from Septembe

245 maceuticals and administered activities from nuclear medicine reports was developed.

246 y to comply with the European Association of Nuclear Medicine Research Ltd.

247 -in conformance with European Association of Nuclear Medicine Research Ltd.

248 ons conform with the European Association of Nuclear Medicine Research Ltd.

249 ard anteroposterior and lateral radiography, nuclear medicine scanning, MR imaging, and CT.

250 radigm and elevate the profile of the entire nuclear medicine sector.

251 Nuclear medicine services should prepare accordingly.

252 he overall results of the survey showed that nuclear medicine services worldwide had been significant

253 gapore, reported a less pronounced impact on nuclear medicine services; however, the overall results

254 olecular Imaging and the American College of Nuclear Medicine should choose the membership of a radio

255 d must educate themselves in both aspects of nuclear medicine so we can fully capitalize on the oppor

256 ceuticals that were submitted to the British Nuclear Medicine Society (BNMS) online database (Radioph

257 as created by one senior radiologist and one nuclear medicine specialist by using all available CT an

258 A senior nuclear medicine specialist in PET for gynecologic oncol

259 Two nuclear medicine specialists determined, in a masked man

260 Similarly, radiologists and nuclear medicine specialists should be sensitized to the

261 f the predicted PET images was assessed by 2 nuclear medicine specialists using a 5-point grading sch

262 ere mainly from Europe (78%), with 22% being nuclear medicine specialists, 42% radiologists, 22% dual

263 In addition, radiologists, nuclear medicine specialists, and radiation oncologists

264 e studies were reviewed by 2 board-certified nuclear medicine specialists, independently.

265 cored 4 or higher (good to excellent) by the nuclear medicine specialists.

266 In these young children, nuclear medicine studies are more likely to be used to e

267 Nuclear medicine studies are often performed in patients

268 The review then will discuss the specific nuclear medicine studies that typically are obtained in

269 resonance imaging; computed tomography; and nuclear medicine studies, including positron emission to

270 patients can benefit from the full range of nuclear medicine studies.

271 ietal practice guidelines for several common nuclear medicine studies.

272 This supplement to The Journal of Nuclear Medicine summarizes the presentations and discus

273 The use of nuclear medicine techniques can add crucial complementar

274 ng-free alternative to techniques like CT or nuclear medicine techniques for the evaluation of lung f

275 Imaging with nuclear medicine techniques plays an important role in d

276 ties such as US, CT and CT arthrography, and nuclear medicine techniques that play a complementary ro

277 int summarises the data regarding the use of nuclear medicine techniques to assess the phases of HSCT

278 Nuclear medicine techniques with application of oncophil

279 contrast to computed tomography (CT) and the nuclear medicine techniques, magnetic resonance imaging

280 nuclear physicians, affiliated researchers, nuclear medicine technologists, and radiation oncologist

281 Potential clinical applications in nuclear medicine that include PET radiomics-based predic

282 In nuclear medicine, the term theranostics describes the co

283 sewhere in this supplement to The Journal of Nuclear Medicine-the management of prostate cancer acros

284 lculation of radiation dosimetry in targeted nuclear medicine therapies is traditionally resource-int

285 lculation of radiation dosimetry in targeted nuclear medicine therapies is traditionally resource-int

286 In nuclear medicine, this expression describes the use of t

287 radiochemistry is an essential component of nuclear medicine; this includes imaging techniques such

288 What will be important is for nuclear medicine to be positioned as the quintessential

289 t is incumbent on practitioners of pediatric nuclear medicine to have an understanding of dosimetry a

290 ve been made for the European Association of Nuclear Medicine to restore its surveys of reported adve

291 Nuclear Medicine convened the Task Force on Nuclear Medicine Training to define the issues and devel

292 tment from 1965 to 2013 at the Department of Nuclear Medicine, University Hospital of Munster, Munste

293 Although nuclear medicine use decreased from 32 to 21 per 1000 en

294 Nuclear medicine uses ionizing radiation for both in viv

295 Therapeutic nuclear medicine uses particulate radiation such as Auge

296 Thus, nuclear medicine views itself as being at a critical cro

297 d decade of the 21(st) century, a new era in nuclear medicine was initiated by the clinical introduct

298 s are critical to numerous fields, including nuclear medicine, waste recycling, space exploration, an

299 nd peptide-like ligands in radiopharmacy and nuclear medicine, we have to conclude that the major adv

300 to trainees seeking to combine expertise in nuclear medicine with high-level abilities in cross-sect

301 n medical imaging and for the integration of nuclear medicine with primary care specialties to be dri